Overview Open Label Study of Sipuleucel-T Status: Completed Trial end date: 0000-00-00 Target enrollment: Participant gender: Summary This is a Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC). Phase: Phase 2 Details Lead Sponsor: Dendreon